Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.530
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.550
+0.020 (1.31%)
After-hours: Mar 9, 2026, 5:38 PM EDT
Daré Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -17.46 | -4.05 | -30.16 | -30.95 | -38.7 | -27.4 | |
| Depreciation & Amortization | 1.11 | 0.04 | 0.04 | 0.02 | 0.03 | 0.04 | |
| Loss (Gain) From Sale of Assets | - | 0.6 | - | - | - | - | |
| Stock-Based Compensation | 1.63 | 2.2 | 2.53 | 2.16 | 1.6 | 0.74 | |
| Other Operating Activities | 0.81 | 0.79 | -0.84 | -0.02 | -0.42 | -0.16 | |
| Change in Accounts Receivable | 0.15 | 0.72 | 0.75 | -0.56 | -0.69 | 0.1 | |
| Change in Accounts Payable | 0.77 | -1.93 | 1.36 | -0.08 | 1.08 | -0.06 | |
| Change in Unearned Revenue | 4.81 | 2.82 | -4.57 | 7.76 | 8.98 | 0.54 | |
| Change in Other Net Operating Assets | 1.97 | 4.2 | -7.97 | 3.57 | -0.65 | 0.96 | |
| Operating Cash Flow | -6.1 | 5.39 | -38.86 | -18.09 | -28.76 | -25.23 | |
| Capital Expenditures | -0.74 | -0.57 | -0.63 | -0.06 | -0.01 | -0.02 | |
| Investing Cash Flow | -0.74 | -0.57 | -0.63 | -0.06 | -0.01 | -0.02 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.37 | |
| Long-Term Debt Issued | - | 0.56 | 0.6 | - | - | - | |
| Total Debt Issued | 0.49 | 0.56 | 0.6 | - | - | 0.37 | |
| Long-Term Debt Repaid | - | -0.58 | -0.33 | - | - | - | |
| Net Debt Issued (Repaid) | -0.99 | -0.02 | 0.27 | - | - | 0.37 | |
| Issuance of Common Stock | 19.71 | 0.45 | 10.65 | 1.34 | 75.85 | 24.76 | |
| Other Financing Activities | -0 | -0 | 4.72 | - | - | - | |
| Financing Cash Flow | 18.72 | 0.43 | 15.64 | 1.34 | 75.85 | 25.13 | |
| Foreign Exchange Rate Adjustments | -0.03 | -0.07 | -0.01 | -0.2 | -0.06 | 0.01 | |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | |
| Net Cash Flow | 11.84 | 5.19 | -23.86 | -17 | 47 | -0.11 | |
| Free Cash Flow | -6.85 | 4.82 | -39.49 | -18.15 | -28.78 | -25.25 | |
| Free Cash Flow Margin | - | 49276.38% | -1406.26% | -181.52% | - | - | |
| Free Cash Flow Per Share | -0.71 | 0.57 | -5.43 | -2.58 | -5.65 | -10.07 | |
| Levered Free Cash Flow | -0.94 | -7.62 | -27.18 | -6.8 | -15.28 | -15.27 | |
| Unlevered Free Cash Flow | -1.05 | -7.62 | -27.18 | -6.8 | -15.28 | -15.27 | |
| Change in Working Capital | 7.7 | 5.81 | -10.43 | 10.7 | 8.73 | 1.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.